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Primary or secondary anaplastic large-cell lymphoma (ALCL) is an uncommon type of T-cell lymphoma 
and is extremely rare.1-3 It was said that only 15-20 cases of primary CNS-ALCLs have been reported 
in the literature.3 ALCL may present with a variety of symptoms and MRI findings. We report a case of 
a 10-year-old girl who presented with meningitis and later developed optic neuritis. She was initially 
diagnosed as tuberculosis meningitis after a positive interferon-γ test. Clinicians should be aware of 
the unusual clinical behavior of primary central nervous system lymphomas (PCNSL). 
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CASE REPORT
A 10-year-old girl presented with fever, headache, 
and vomiting for 7 days. A lumbar puncture 
revealed 26 white blood cells, 8 red blood 
cells, protein 45 mg/dl, and glucose 67 mg/dL. 
The initial computed tomography (CT) scan 
was normal and she was diagnosed with viral 
meningitis. However, after discharge, symptoms 
recurred and a repeat cerebrospinal fluid analysis 
showed 41 white blood cells. Despite treatment 
with antibiotics, intermittent fever lasted for 15 
days. The patient was transferred to our hospital 
for evaluation of possible tuberculosis meningitis 
as there was a history of contact with a tuberculosis 
patient. Initial brain MRI showed leptomeningeal 
enhancement, consistent with leptomeningitis 
due to an infectious etiology. (Figure 1A) There 
was no lymphadenopathy or organomegaly. The 
laboratory findings revealed an elevated serum 
white blood cell count of 15,360/mm3 and positive 
interferon-γ (IGRA). Although the Mantoux 
test, sputum mycobacterium cultures, CSF, and 
Figure 1. A). Brain MRI in March 2013, enhanced T1 series showed leptomeningeal enhancement in the left 
hemisphere. B). Brain MRI in April 2013, enhanced T1 series revealed improved leptomeningeal 
enhancement.
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acid fast bacilli (AFB) stain were all negative, a 
presumptive diagnosis of tuberculosis meningitis 
was made and empiric treatment of tuberculosis 
meningitis was started with the following 4-drug 
regimen: isoniazid, rifampin, pyrazinamide, and 
ethambutol. 
 One month later in April 2013, the patient 
presented to the emergency room with pain of the 
right eye. There was eye pain that worsened with 
eye movement. An orbital MRI showed evidence 
of right optic nerve enhancement (Figure 2A). 
On ophthalmologic examination, the anterior 
segment of the right eye was unremarkable, but 
an infiltrative optic neuropathy was suspected. 
The optic neuritis was presumed to be associated 
with tuberculosis, and thus all medications were 
continued except ethambutol due to the possibility 
of ethambutol-induced optic neuritis. 
 Two weeks after discharge in May 2013, she 
developed morning headaches with vomiting and 
complex partial seizures with right facial and lip 
twitching. Repeat MRI showed an enhancing, 
homogenous lesion in the left parietal area. 
(Figure 3B) An excisional biopsy of the lesion 
revealed large lymphoma cells with vesicular 
nuclei and prominent nucleoli. And It was Ki-1 
and anaplastic lymphoma kinase (ALK) positive 
and highlighted by positive staining for CD30 and 
CD45. (Figure 4) The patient was treated with 
chemotherapy including high dose methotrexate. 
After chemotherapy, optic neuropathy, headache, 
and fever improved.
DISCUSSION
According to the literature, the usual interval 
between initial presentation and final diagnosis of 
PCNSL is approximately 3 months.4 The patients 
may present with a wide variety of symptoms 
and radiologic findings may be confused with 
other lesions.5 Our patient was first diagnosed 
with tuberculosis meningitis due to the presence 
of fever, vomiting, headache, leptomeningeal 
enhancement on MRI, and positive interferon-γ. 
The majority (60%-85%) of ALCLs are ALK 
positive lymphomas that exhibit the characteristic 
t(2;5)(p23;q23) translocation to produce the ALK 
protein. ALK expression is considered to be a 
primary oncogenic event in ALCL.6
 On the second admission, the patient presented 
with optic neuritis. Although there are case reports 
of ALCL involving the ocular adnexa7 and optic 
nerve8, they are exceptionally rare. Other than 
direct lymphomatous infiltration of the optic nerve, 
there was also report of possible epidemiologic 
association between multiple sclerosis (MS) and 
lymphoma.9 
 In our patient, the initial MRI scan showed optic 
nerve enhancement. The symptoms improved on 
follow-up MRI after steroid therapy. (Figure 2B) 
We also considered the possibility of ethambutol-
induced ocular toxicity. But, the optic nerve 
enhancement in MRI was not consistent with the 
diagnosis.
 According to the literature10, PCNSL on MRI 
usually appear as hypointense (53%) or isointense 
Figure 2. A). Brain MRI in April 2013, enhanced T1 series showed the enhanced sheath of the right optic nerve. 
B). Brain MRI in May 2013, T2 series demonstrated improved inflammatory changes in the right optic 
nerve.
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(37%) lesions on T1-weighted images and more 
commonly as hyperintense (42%) or isointense 
(37%) lesions on T2-weighted images. Meningeal 
enhancement without an associated intracranial 
mass is rare in PCNSL. In our patient, the 
initial MRI findings included leptomeningeal 
enhancement and repeat MRI showed a well-
circumscribed homogeneous enhancing lesion in 
Figure 4. These figures showed large pleomorphic cells with pleomorphic neuclei in stained with hematoxylin and 
eosin stain (X 200, A) and immunohistochemical stain (B: ALK stain; C: CD30; D: CD45)
Figure 3. A). Brain MRI in April 2013, T1 series showed a lesion on the location where a mass lesion would later 
be found. B). Brain MRI in May 2013, T2 series revealed a well-circumscribed homogeneous hyperintense 
lesion in the parietal area.
the parietal area. (Figure 3B) Upon further review 
of the earlier MRI, there was a lesion where the 
mass lesion was later found. (Figure 3A) 
 In summary, ALCL is an uncommon lymphoma 
with a variety of different symptoms and MRI 
findings. Clinicians should be aware of the unusual 
clinical behavior of PCNSL. 
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